The overall goal of the Moffitt Cancer Center (MCC) Health Outcomes and Behavior (HOB) Program is to contribute to the prevention, detection, and control of cancer through the study of health-related behaviors, health care practices, and health-related quality of life. Work toward this goal involves research across the disease spectrum ? from prevention and detection through to survivorship or advanced disease. To accomplish its goal, the Program's Specific Aims are: (1) Understand the determinants of behaviors that can lead to prevention and early detection of cancer and develop effective methods of promoting those behaviors; (2) Understand and improve the quality of life of patients and family members throughout the disease course; (3) Contribute to the evidence base, and synthesis of evidence, regarding delivery of cancer care and clinical outcomes; and (4) Understand and intervene upon the social, cultural, and behavioral determinants of cancer- related health disparities. The program comprises 27 members [20 MCC faculty; seven University of South Florida (USF) faculty] from 12 different academic departments (six MCC and six USF). During the reporting period, 547 cancer-related articles have been published, with 218 (40%) representing intra-programmatic collaborations and 135 (25%) representing inter-programmatic collaborations. Inter-institutional collaborations with other NCI-designated Cancer Centers represent 164 (30%) of the publications. Total grant funding for the program currently is $9.1 million in annual total costs, of which $7.5 million is peer-reviewed, including $3.0 million from NCI. Program members conduct hypothesis-driven observational and intervention research on the major cancers affecting the catchment area?lung, prostate, breast, colorectal, cervical?with respect to prevention, screening, quality of life, cancer care delivery, and outcomes. Additionally, toward the goal of reducing cancer- related health disparities, program members conduct community-based participatory research in concert with organizations embedded in the catchment area. In collaboration with colleagues from other programs and institutions, translational research by HOB members is driving public health policy and clinical practice.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA076292-19
Application #
9209829
Study Section
Subcommittee A - Cancer Centers (NCI-A)
Project Start
Project End
Budget Start
2017-02-01
Budget End
2018-01-31
Support Year
19
Fiscal Year
2017
Total Cost
$31,374
Indirect Cost
$13,133
Name
H. Lee Moffitt Cancer Center & Research Institute
Department
Type
Research Institutes
DUNS #
139301956
City
Tampa
State
FL
Country
United States
Zip Code
33612
Martínez, Úrsula; Brandon, Thomas H; Sutton, Steven K et al. (2018) Associations between the smoking-relatedness of a cancer type, cessation attitudes and beliefs, and future abstinence among recent quitters. Psychooncology 27:2104-2110
Perales-Puchalt, Alfredo; Perez-Sanz, Jairo; Payne, Kyle K et al. (2018) Frontline Science: Microbiota reconstitution restores intestinal integrity after cisplatin therapy. J Leukoc Biol 103:799-805
Davis, Stacy N; Govindaraju, Swapamthi; Jackson, Brittany et al. (2018) Recruitment Techniques and Strategies in a Community-Based Colorectal Cancer Screening Study of Men and Women of African Ancestry. Nurs Res 67:212-221
Singh, Kshipra; Coburn, Lori A; Asim, Mohammad et al. (2018) Ornithine Decarboxylase in Macrophages Exacerbates Colitis and Promotes Colitis-Associated Colon Carcinogenesis by Impairing M1 Immune Responses. Cancer Res 78:4303-4315
Kasting, Monica L; Giuliano, Anna R; Reich, Richard R et al. (2018) Hepatitis C Virus Screening Trends: Serial Cross-Sectional Analysis of the National Health Interview Survey Population, 2013-2015. Cancer Epidemiol Biomarkers Prev 27:503-513
Nelson, Ashley M; Jim, Heather S L; Small, Brent J et al. (2018) Sleep disruption among cancer patients following autologous hematopoietic cell transplantation. Bone Marrow Transplant 53:307-314
Betts, Brian C; Bastian, David; Iamsawat, Supinya et al. (2018) Targeting JAK2 reduces GVHD and xenograft rejection through regulation of T cell differentiation. Proc Natl Acad Sci U S A 115:1582-1587
Pidala, Joseph; Beato, Francisca; Kim, Jongphil et al. (2018) In vivo IL-12/IL-23p40 neutralization blocks Th1/Th17 response after allogeneic hematopoietic cell transplantation. Haematologica 103:531-539
Denson, Aaron; Burke, Nancy; Wapinsky, Georgine et al. (2018) Clinical Outcomes of Patients With Gastrointestinal Malignancies Participating in Phase I Clinical Trials. Am J Clin Oncol 41:133-139
Hoogland, Aasha I; Lechner, Suzanne C; Gonzalez, Brian D et al. (2018) Efficacy of a Spanish-Language Self-Administered Stress Management Training intervention for Latinas undergoing chemotherapy. Psychooncology 27:1305-1311

Showing the most recent 10 out of 1254 publications